Digipath
Home > Boards > US OTC > Biotechs >

Amarantus Bioscience Holdings Inc. (AMBS)

AMBS RSS Feed 		Add AMBS Price Alert      Hide Sticky   Hide Intro
Moderator: JPetroInc
Search This Board: 
Last Post: 12/10/2018 8:25:32 PM - Followers: 676 - Board type: Free - Posts Today: 0

 

(AMBS) Amarantus BioScience Holdings, Inc. 

Amarantus is a biotechnology company developing treatments and diagnostics for diseases associated with neurodegeneration and protein misfolding-related apoptosis.
The company has licensed Eltoprazine, a Phase 3 ready Parkinsons Levadopa induced Dyskinesia.
 (MANF) is a human growth factor that plays a key role in the prevention of apoptosis (cell death). It is being developed for the potential treatment of RP, Parkinson's disease, Wolfram syndrome, diabetes, Alzheimer's disease and traumatic brain injury.
ESS, previously known as PermaDerm®  is being developed to be the only tissue-engineered skin prepared from autologous (patient's own) skin cells consisting of both epidermal and dermal layers. A small harvested section of the patient's own skin can be grown to graft an area one hundred times its size in as little as thirty days. 
For further information, please visit www.Amarantus.com, or connect with the company in Facebook, Twitter, LinkedIn & Google+
 
                                                                                       
 

NEWS


Bio-engineering skin to treat severe burns
 
 

   Videos

 

Gerald Commissiong, CEO of Amarantus BioScience Holdings, Inc. (OTCQX: AMBS) chats with Bob Power, OTC Markets VP of Corporate Services
Mar. 18, 2016

 
SNNLive with Amarantus Bioscience Holdings, Inc. (OTCQX: AMBS)  
December 2015


 

ESS Patients: Dr. Ahrenholz Interview Part 1 
 
ESS vs the Competition: Dr. Ahrenholz Interview Part 2

The Need for ESS: Dr. Ahrenholz Interview Part 3		  
 
 
 
                                                                                                                
 
 
    
       
 


                                                               Contact Information

Amarantus BioScience Holdings, Inc.
655 Montgomery Street
Suite 900
San Francisco, CA 94111
 

c/o ICS Corporate Services SA
29 quai du Mont Blanc
CH-1201 Geneva
Switzerland












 
info@amarantus.com
pr@amarantus.com

Phone: (415) 688-4484
Fax: (408) 852-4427


Gerald's email address
Gerald@amarantus.com


IR Calendar 






 

INVESTOR RELATIONS

Jenene Thomas Communications
Jenene Thomas
T: 908-938-1475
ir@amarantus.com


 

TRANSFER AGENT

VStock Transfer, LLC
Allison Niccols
77 Spruce Street
Suite 201
Cedarhurst, N 11516
T: 212-828-8436
F: 646-536-3179
info@vstocktransfer.com
www.VStockTransfer.com

 
 
 
                                                                            

 

Digipath
AMBS
Current Price
Volume:
Bid Ask Day's Range
AMBS Detailed Quote
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
AMBS News: Coeptis Pharma Enters into Agreement to Acquire Elto Pharma 11/28/2018 07:30:00 AM
AMBS News: Amarantus Provides Corporate Update 07/20/2018 07:31:51 AM
AMBS News: MANF Therapeutics Announces Positive MANF Pre-Clinical Data in Alpha-Synuclein Model of Parkinson's Disease Published in 07/09/2018 08:00:00 AM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#128357  Sticky Note what are you talking about? JPetroInc 06/16/18 01:00:07 PM
#128786   Printing $0.01’s JPetroInc 12/10/18 08:25:32 PM
#128785   Geraldo's unloading assets onto other stinky pinky's at JPetroInc 12/05/18 02:19:28 PM
#128784   what garbage JPetroInc 12/04/18 01:12:52 PM
#128783   How do you say in espanol, "GERALD IS SidVicious 12/03/18 11:52:51 AM
#128782   more like a joint failure! LOL ROFL PIMPL! SidVicious 12/03/18 11:30:14 AM
#128781   It’s a joint venture jeffshir 12/03/18 11:06:55 AM
#128780   First, Gerald ruined TODOS investment in AMBS and SidVicious 12/03/18 10:48:40 AM
#128779   Venture Agreement with Amarantus to develop Alzheimer’s Blood zoomboom 12/03/18 08:41:37 AM
#128778   Sure looks like AMBS closing up shop. Joeblow21 12/03/18 08:38:30 AM
#128777   Just gave away Lymppro to Todos Medical, a Joeblow21 12/03/18 08:37:28 AM
#128775   what hooey - what a scam JPetroInc 11/29/18 02:52:11 AM
#128774   Wouldn’t adding CBD oil to its offerings and breezy1 11/28/18 01:26:13 PM
#128773   Wouldn’t adding CBD oil to its offerings and breezy1 11/28/18 01:26:00 PM
#128772   Gerald and his dad are CO-INEPTUS! SidVicious 11/28/18 11:12:47 AM
#128771   Should read steals not buys as ambs will SidVicious 11/28/18 10:50:23 AM
#128770   Coeptis Pharma Buys Elto Pharma for Phase II zoomboom 11/28/18 10:24:50 AM
#128769   https://www.biospace.com/article/coeptis-pharma-to-buy-elto-pharma/ zoomboom 11/28/18 10:24:17 AM
#128768   LMAO! a surfer 11/28/18 09:54:50 AM
#128767   The deal is that Coeptis will exclusively use SidVicious 11/28/18 09:49:37 AM
#128766   Coeptis website is a joke. Look at Joeblow21 11/28/18 09:45:53 AM
#128765   Yep exactly. Gerald probably raised just enough Joeblow21 11/28/18 09:19:54 AM
#128764   AMBS bulls called Elto a 9-figure asset lol. Joeblow21 11/28/18 09:13:51 AM
#128763   When you are in no position to negotiate SidVicious 11/28/18 09:08:57 AM
#128761   interesting that there is no dollar amount mentioned. SidVicious 11/28/18 08:45:43 AM
#128760   LOL @ no dollar amount was given. That's SidVicious 11/28/18 08:42:33 AM
#128759   Coeptis Pharma Enters into Agreement to Acquire Elto zoomboom 11/28/18 08:07:54 AM
#128758   LOL... Coeptis Pharma Enters into Agreement to Acquire Elto Pharma a surfer 11/28/18 07:57:58 AM
#128757   LOL @ Gerald's business plan! SidVicious 11/17/18 07:03:39 AM
#128756   yup - what a lying Conman... JPetroInc 11/13/18 07:37:44 PM
#128755   Lol zoomboom 11/13/18 12:35:40 PM
#128754   Ain't funny Zoom. We've all had our money 7Bullet7 11/13/18 11:29:38 AM
#128752   Lol zoomboom 11/13/18 09:47:09 AM
#128751   We? We aren't going to get paid squat. SidVicious 11/13/18 07:43:58 AM
#128750   nah. we about to get paid. not enough freegriff 11/12/18 11:32:55 PM
#128749   Hopefully the sec will catch up with Gerald SidVicious 11/12/18 10:07:15 PM
#128748   SEC caught SeeThru Tandon brothers,just like the other newflow 11/12/18 07:39:42 PM
#128747   No worries... JPetroInc 11/10/18 06:08:21 AM
#128746   Sounds exactly Geraldo JPetroInc 11/10/18 06:05:50 AM
#128744   How's that business plan working out? Has Gerald SidVicious 11/10/18 05:35:51 AM
#128743   They are also looking into the fake analysts zoomboom 11/10/18 12:39:51 AM
#128742   SeeThru Equities under SEC investigation JPetroInc 11/09/18 10:31:13 PM
#128741   Get a life zoomboom 11/09/18 10:22:30 PM
#128740   sad turn for AMBS printing $0.02 JPetroInc 11/09/18 08:32:37 PM
#128739   Bump itwentdwnhwmch 11/09/18 04:56:22 PM
#128738   How original zoomboom 11/09/18 03:04:31 PM
#128737   Merger ? The merger of nothing and nothing 7Bullet7 11/09/18 02:20:45 PM
#128736   I think that if AMBS can enter the Stuville 11/08/18 07:21:12 PM
#128735   very possible. could also be printing .10's and freegriff 11/07/18 06:19:15 PM
#128734   Printing .01's tomorrow ? 7Bullet7 11/07/18 05:48:15 PM
#128733   https://www.otcmarkets.com/stock/AMBS/disclosure zoomboom 11/05/18 09:23:58 AM
PostSubject
© 2018 InvestorsHub.com, Inc.